J
Jeff M. Michalski
Researcher at Washington University in St. Louis
Publications - 393
Citations - 24291
Jeff M. Michalski is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 73, co-authored 330 publications receiving 20977 citations. Previous affiliations of Jeff M. Michalski include American Urological Association & American Society for Radiation Oncology.
Papers
More filters
Journal ArticleDOI
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Robert Timmerman,Rebecca Paulus,James M. Galvin,Jeff M. Michalski,William L. Straube,Jeffrey D. Bradley,Achilles J. Fakiris,Andrea Bezjak,Gregory M.M. Videtic,David W. Johnstone,Jack F. Fowler,Elizabeth Gore,Hak Choy +12 more
TL;DR: Patients with inoperable non-small cell lung cancer who received stereotactic body radiation therapy had a survival rate of 55.8% at 3 years, high rates of local tumor control, and moderate treatment-related morbidity.
Journal ArticleDOI
Quality of life and satisfaction with outcome among prostate-cancer survivors.
Martin G. Sanda,Rodney L. Dunn,Jeff M. Michalski,Howard M. Sandler,Laurel L. Northouse,Larry Hembroff,Xihong Lin,Thomas K. Greenfield,Mark S. Litwin,Mark S. Litwin,Christopher S. Saigal,Arul Mahadevan,Eric A. Klein,Adam S. Kibel,Louis L. Pisters,Deborah A. Kuban,Irving D. Kaplan,Darien Wood,Jay P. Ciezki,Nikhil L. Shah,John T. Wei +20 more
TL;DR: Each prostate-cancer treatment was associated with a distinct pattern of change in quality-of-life domains related to urinary, sexual, bowel, and hormonal function, and these changes influenced satisfaction with treatment outcomes among patients and their spouses or partners.
Journal ArticleDOI
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson,Peter T. Scardino,Michael W. Kattan,Thomas M. Pisansky,Kevin M. Slawin,Eric A. Klein,Mitchell S. Anscher,Jeff M. Michalski,Howard M. Sandler,Daniel W. Lin,Jeffrey D. Forman,Michael J. Zelefsky,Larry L. Kestin,Claus G. Roehrborn,Charles Catton,Theodore L. DeWeese,Stanley L. Liauw,Richard K. Valicenti,Deborah A. Kuban,Alan Pollack +19 more
TL;DR: Nearly half of patients with recurrent prostate cancer after radical prostatectomy have a long-term PSA response to SRT when treatment is administered at the earliest sign of recurrence, which should prove valuable for medical decision making for patients with a rising PSA level.
Journal ArticleDOI
Radiation Dose–Volume Effects in Radiation-Induced Rectal Injury
TL;DR: In this article, the available dose/volume/outcome data for rectal injury were reviewed, and the authors found that the volume of rectum receiving ≥60Gy is consistently associated with the risk of Grade ≥2 rectal toxicity or rectal bleeding.
Journal ArticleDOI
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
Sam S. Chang,Bernard H. Bochner,Roger Chou,Robert Dreicer,Ashish M. Kamat,Seth P. Lerner,Yair Lotan,Joshua J. Meeks,Jeff M. Michalski,Todd M. Morgan,Diane Zipursky Quale,Jonathan E. Rosenberg,Anthony L. Zietman,Jeffrey M. Holzbeierlein +13 more
TL;DR: This guideline attempts to improve a clinician's ability to evaluate and treat each patient, but higher quality evidence in future trials will be essential to improve level of care for these patients.